Necrotizing colitis caused by systemic aspergillosis in a burn patient

被引:7
作者
Andres, Lewis A.
Ford, Ronald D.
Wilcox, Richard M.
机构
[1] Michigan State Univ, Grand Rapids Med Educ & Res Ctr, Plast & Reconstruct Surg Residency Program, E Lansing, MI 48824 USA
[2] Michigan State Univ, Div Plast & Reconstruct Surg, Grand Rapids, MI 48824 USA
[3] Michigan State Univ, Dept Gen Surg, Grand Rapids, MI 48824 USA
关键词
D O I
10.1097/BCR.0b013e318159a3d8
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
The incidence of invasive fungal infections has continued to rise over the past three decades, especially in the immunocompromised and intensive care unit population. Candida species are the most common pathogen to cause such invasive infections. However, Aspergillus species are currently on the rise and constitute a much more aggressive and serious infection. All Aspergillus species cause a wide spectrum of diseases from colonization to hypersensitivity reactions. It can also cause chronic necrotizing infections leading to rapidly progressive angioinvasion, often resulting in death. Invasive Aspergillus infection almost always occurs in patients who are immunosuppressed. We report here a case of aspergillosis causing invasive systemic infection and mycotic colitis in a burn patient. The clinical presentation was one of septic shock with rapidly progressing dissemination leading to necrotizing colitis and eventual demise. Pathologic findings involved necrotizing enterocolitis with invasive Aspergillus hyphae. Given the rarity of this entity and usual progression to death in humans, proper diagnosis and treatment of such fungal infections are being investigated. Reports are reviewed, and possible mechanisms resulting in Aspergillus infection in this individual are discussed.
引用
收藏
页码:918 / 921
页数:4
相关论文
共 7 条
  • [1] Invasive fungal infections: evolving challenges for diagnosis and therapeutics
    Ellis, M
    [J]. MOLECULAR IMMUNOLOGY, 2002, 38 (12-13) : 947 - 957
  • [2] Kullberg BJ, 2002, EUR J MED RES, V7, P183
  • [3] Assessing risk factors for systemic fungal infections
    Maertens, J
    Vrebos, M
    Boogaerts, M
    [J]. EUROPEAN JOURNAL OF CANCER CARE, 2001, 10 (01) : 56 - 62
  • [4] FUNGAL-INFECTIONS OF THE SMALL AND LARGE-INTESTINE
    PRESCOTT, RJ
    HARRIS, M
    BANERJEE, SS
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1992, 45 (09) : 806 - 811
  • [5] Rolston K, 2001, Oncology (Williston Park), V15, P11
  • [6] Skin involvement as the first manifestation of systemic aspergillosis in patients after allogeneic hematopoietic cell transplantation
    Schimmelpfennig, C
    Naumann, R
    Zuberbier, T
    Ordemann, R
    Baurmann, H
    Beyer, J
    Siegert, W
    Bornhäuser, M
    Ehninger, G
    [J]. BONE MARROW TRANSPLANTATION, 2001, 27 (07) : 753 - 755
  • [7] Candidosis and aspergillosis as autopsy findings from 1994 to 2003
    Schwesinger, G
    Junghans, D
    Schröder, G
    Bernhardt, H
    Knoke, M
    [J]. MYCOSES, 2005, 48 (03) : 176 - 180